The Genetic and Scientific Basis, Molecular Biology, and Mechanistic Rationale for Lowering LDL Through PCSK9 Inhibition - Translating Genetic and Epidemiologic Evidence to the Front Lines of Clinical Research and Patient Care - Thomas P. Bersot, M.D., Ph.D.